MyMD Pharmaceuticals Price on March 29, 2024

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
If you're considering investing in MyMD Stock, it is important to understand the factors that can impact its price. As of today, the current price of MyMD Pharmaceuticals stands at 1.82, as last reported on the 25th of December, with the highest price reaching 1.89 and the lowest price hitting 1.82 during the day. We have found twenty-three technical indicators for MyMD Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify MyMD Pharmaceuticals' mean deviation of 3.6, and Risk Adjusted Performance of (0.11) to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
MyMD Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
MYMD
Based on monthly moving average MyMD Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MyMD Pharmaceuticals by adding MyMD Pharmaceuticals to a well-diversified portfolio.

Related Headline

Recursion Pharmaceuticals Headline on 28th of March 2024

Filed transaction by Recursion Pharmaceuticals Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

MyMD Pharmaceuticals Valuation on March 29, 2024

It is possible to determine the worth of MyMD Pharmaceuticals on a given historical date. On March 29, 2024 MyMD was worth 2.45 at the beginning of the trading date compared to the closed value of 2.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MyMD Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find MyMD Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MyMD Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MyMD Pharmaceuticals' related companies.
 Open High Low Close Volume
  2.29    2.35    2.29    2.35    10,308  
03/28/2024
  2.45    2.45    2.31    2.39    32,983  
  2.40    2.45    2.24    2.27    44,808  
Backtest MyMD Pharmaceuticals  |  MyMD Pharmaceuticals History  |  MyMD Pharmaceuticals Valuation   PreviousNext  
Open Value
2.45
2.39
Closing Value
2.45
Upside

MyMD Pharmaceuticals Trading Date Momentum on March 29, 2024

On April 01 2024 MyMD Pharmaceuticals was traded for  2.27  at the closing time. The top price for the day was 2.45  and the lowest listed price was  2.24 . The trading volume for the day was 44.8 K. The trading history from April 1, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.02% . The trading delta at closing time against the current closing price is 11.72% .

MyMD Pharmaceuticals Fundamentals Correlations and Trends

By evaluating MyMD Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MyMD Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MyMD financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About MyMD Pharmaceuticals Stock history

MyMD Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MyMD is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MyMD Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MyMD Pharmaceuticals stock prices may prove useful in developing a viable investing in MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company was founded in 2014 and is headquartered in Baltimore, Maryland. Mymd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.

MyMD Pharmaceuticals Stock Technical Analysis

MyMD Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of MyMD Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of MyMD Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

MyMD Pharmaceuticals Period Price Range

Low
December 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

MyMD Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

MyMD Pharmaceuticals December 25, 2024 Market Strength

Market strength indicators help investors to evaluate how MyMD Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MyMD Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying MyMD Pharmaceuticals stock market strength indicators, traders can identify MyMD Pharmaceuticals entry and exit signals to maximize returns

MyMD Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for MyMD Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of MyMD Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MyMD to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges